Are your residents who do not have dementia excessively sleepy during the daytime? If so, then they may be at risk for an increased accumulation of a brain protein that is a biomarker for Alzheimer’s...
One in three Alzheimer’s, dementia cases tied to modifiable risk factors
May 11, 2022
Risk factors differ based on sex and race and ethnicity.
Can we please quit calling them Alzheimer’s patients?
By
John O'Connor
Mar 31, 2016
With all due respect to Alzheimer’s, the brand needs an overhaul.
More news for Tuesday, June 20
Jun 19, 2017
Senate GOP considers deeper Medicaid cuts than House bill … The Senate is close to a healthcare bill, but do Republicans have the votes? … FDA approves MRSA drug … Cleveland Clinic receives...
Skilled nursing claims continue to be eclipsed by assisted living claims by average cost, CNA reports
By
Kathleen Steele Gaivin
Mar 18, 2022
The average cost of assisted living professional liability claims ($267,174) has outpaced such claims by skilled nursing facilities ($245,559) over the past few years, according to the 11th edition of...
Dementia, affordable housing advocates cheer spending bill provisions
By
Lois A. Bowers
Mar 23, 2018
Supporters of Alzheimer’s disease-related health promotion, dementia research, falls prevention and affordable housing are cheering provisions contained in a $1.3 trillion, 2,232-page fiscal year...
Silent sentinels
By
Julie E. Williamson
May 11, 2017
Operators are adopting innovative, unobtrusive and increasingly silent security solutions that can be tailored to meet the needs of each resident in your community.
Keep it real with evidence-based simulation learning
By
Melora Jackson, MS
Aug 02, 2019
Scientifically researched training tools offer assurances that do-it-yourself and knock-off training programs cannot ensure.
Moving more may help older adults maintain memory, study finds
By
Lois A. Bowers
Jan 18, 2019
Staying active in old age may help memory and thinking, according to a study published in Neurology, the medical journal of the American Academy of Neurology.
FDA approves first treatment for Alzheimer’s in 18 years
By
Kimberly Bonvissuto
Jun 07, 2021
The first novel therapy for Alzheimer’s disease in almost two decades was approved today by the Food & Drug Administration.